Sage Therapeutics Inc (SAGE):企業の財務・戦略的SWOT分析

◆英語タイトル:Sage Therapeutics Inc (SAGE) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH357890FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sage Therapeutics Inc (SAGE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sage Therapeutics Inc (Sage) is a clinical-stage biopharmaceutical company that discovers, develops and markets therapeutics and medicines for central nervous system (CNS) disorders. It develops drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors of NMDA and GABA. Its flagship product Zulresso (brexanolone) is a proprietary intravenous (IV) formulation administered for the treatment of postpartum depression (PPD). The company also has various pipeline products for the treatment of indications such as postpartum depression, major depressive disorders, bipolar depression, Parkinson’s disease, insomnia, epileptiform disorders, and NMDA hypofunction. The company through its subsidiaries operates in the US, Bermuda, Netherlands, Switzerland, England and Wales. Sage is headquartered in Cambridge, Massachusetts, the US.

Sage Therapeutics Inc Key Recent Developments

Apr 20,2021: Sage Therapeutics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
Mar 16,2021: Sage Therapeutics Announces Departure of Chief Operating Officer
Feb 24,2021: Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Feb 11,2021: Sage Therapeutics to Present at Upcoming Investor Conferences
Feb 10,2021: Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sage Therapeutics Inc – Key Facts
Sage Therapeutics Inc – Key Employees
Sage Therapeutics Inc – Key Employee Biographies
Sage Therapeutics Inc – Major Products and Services
Sage Therapeutics Inc – History
Sage Therapeutics Inc – Company Statement
Sage Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Sage Therapeutics Inc – Business Description
R&D Overview
Sage Therapeutics Inc – Corporate Strategy
Sage Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Sage Therapeutics Inc – Strengths
Sage Therapeutics Inc – Weaknesses
Sage Therapeutics Inc – Opportunities
Sage Therapeutics Inc – Threats
Sage Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sage Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 20, 2021: Sage Therapeutics to Report First Quarter 2021 Financial Results on Tuesday, May 4, 2021
Mar 16, 2021: Sage Therapeutics Announces Departure of Chief Operating Officer
Feb 24, 2021: Sage Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Highlights Pipeline and Business Progress
Feb 11, 2021: Sage Therapeutics to Present at Upcoming Investor Conferences
Feb 10, 2021: Sage Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 24, 2021
Jan 07, 2021: Sage Therapeutics provides 2021 corporate strategy update at J.P. Morgan Healthcare Conference
Dec 16, 2020: Sage Therapeutics announces the appointment of Barry Greene as CEO
Nov 30, 2020: Biogen, Sage Therapeutics sign deal to develop depression, tremor therapies
Nov 05, 2020: Sage Therapeutics announces third quarter 2020 financial results and highlights pipeline and business progress
Oct 01, 2020: Sage Therapeutics appoints Barry Greene to Board of Directors
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sage Therapeutics Inc, Key Facts
Sage Therapeutics Inc, Key Employees
Sage Therapeutics Inc, Key Employee Biographies
Sage Therapeutics Inc, Major Products and Services
Sage Therapeutics Inc, History
Sage Therapeutics Inc, Subsidiaries
Sage Therapeutics Inc, Key Competitors
Sage Therapeutics Inc, Ratios based on current share price
Sage Therapeutics Inc, Annual Ratios
Sage Therapeutics Inc, Annual Ratios (Cont...1)
Sage Therapeutics Inc, Interim Ratios
Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sage Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Sage Therapeutics Inc (SAGE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that offers research and development of traditional Chinese medicine. The institute provides solutions in the areas of drug discovery and drug development. It also provides studies of …
  • Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Implenia AG:戦略・SWOT・企業財務分析
    Implenia AG - Strategy, SWOT and Corporate Finance Report Summary Implenia AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MAXrad SOFTware (India) Pvt Ltd:企業の戦略・SWOT・財務分析
    MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report Summary MAXrad SOFTware (India) Pvt Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • L Brands Inc:戦略・SWOT・企業財務分析
    L Brands Inc - Strategy, SWOT and Corporate Finance Report Summary L Brands Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Skipton Building Society (SKIP):企業の財務・戦略的SWOT分析
    Skipton Building Society (SKIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • BlueCrest Energy Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary BlueCrest Energy Inc (BlueCrest) is a privately held exploration and production company. The company primary focused on the extraction, acquisition, drilling, developing, and exploration of oil and gas resources within Alaska, the US. BlueCrest’ soil and gas assets are located approximately …
  • ProteoMediX AG:医療機器:M&Aディール及び事業提携情報
    Summary ProteoMediX AG (ProteoMediX) is a medical diagnostic company that identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection …
  • Ford Motor Company:戦略・SWOT・企業財務分析
    Ford Motor Company - Strategy, SWOT and Corporate Finance Report Summary Ford Motor Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Active Implants LLC:医療機器:M&Aディール及び事業提携情報
    Summary Active Implants LLC (Active Implants), formerly Active Implants Corp is a medical equipment provider that develops orthopedic equipment. The company develops and commercializes polymer orthopedic implant solutions which include tribofit hip system, tribofit instrumentation equipment, NuSurfa …
  • Weifa ASA (WEIFA)-製薬・医療分野:企業M&A・提携分析
    Summary Weifa ASA (Weifa), formerly Aqualis ASA, is a pharmaceutical company that conducts the research and development, manufacture, distribution and sales of pharmaceutical products, lifestyle products and solutions. The company has over the counter (OTC) pharmaceutical market in Norway offering p …
  • Ocean Bio-Chem Inc (OBCI):企業の財務・戦略的SWOT分析
    Summary Ocean Bio-Chem Inc (OBCI) is a chemical manufacturing company that manufactures and markets maintenance and appearance products. The company's products include star brite products, performacide products, star tron products, and odor star products, among others. Its star tron products compris …
  • Shri Lakshmi Cotsyn Ltd.:企業の戦略・SWOT・財務分析
    Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shri Lakshmi Cotsyn Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lebara Group:企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Actinogen Medical Ltd (ACW):企業の財務・戦略的SWOT分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company’s xanamem is a novel drug under development for …
  • Arvinas Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arvinas Inc (Arvinas) is a biopharmaceutical company that develops protein degradation therapeutics. The company develops novel therapeutics for the treatment of pro-inflammatory, cancer, autoimmune and rare diseases. Its proprietary approach is to target disease causing proteins. Arvinas’s …
  • Bankers Insurance Group:企業の戦略・SWOT・財務情報
    Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Bankers Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PECO Energy Co:企業の戦略的SWOT分析
    PECO Energy Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆